Urovant Sciences Ltd. (26) | Business Operations (6)
Browse by Subcategory
Recent Contracts
-
First Amendment to Market Access Services Agreement, dated December 21, 2020, by and between the Company and Sunovion Pharmaceuticals, Inc
(Filed With SEC on February 12, 2021)
-
Voting and Support Agreement, dated as of November 12, 2020, between Urovant Sciences Ltd. and Sumitovant Biopharma Ltd
(Filed With SEC on November 13, 2020)
-
Information Sharing and Cooperation Agreement, dated May 21, 2020, by and between Urovant Sciences, Ltd. and Sumitovant Biopharma Ltd
(Filed With SEC on May 28, 2020)
-
Form of Indemnification Agreement with officers and directors
(Filed With SEC on April 6, 2020)
-
Second Amendment to Market Access Services Agreement, dated January 8, 2021, by and between the Company and Sunovion Pharmaceuticals, Inc
(Filed With SEC on February 12, 2021)
-
Market Access Services Agreement, dated June 17, 2020, by and between the Company and Sunovion Pharmaceuticals Inc
(Filed With SEC on August 13, 2020)